Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rene Geissler

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 14, 2017
Characterizing mRNA Sequence Motifs in the 3'-UTR Using GFP Reporter ConstructsRene Geissler, Andrew Grimson
RNA Biology|August 27, 2016
A position-specific 3'UTR sequence that accelerates mRNA decayRene Geissler, Andrew Grimson
Nucleic Acids Research|February 11, 2012
The DEAD-box helicase DDX3 supports the assembly of functional 80S ribosomesRene Geissler, Ralph P Golbik, Sven-Erik Behrens
Plos Genetics|February 4, 2020
Evolutionary dynamics of microRNA target sites across vertebrate evolutionAlfred Simkin, Rene Geissler, Alexa B R McIntyre, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 5, 2023
Novel fully automated prototype assays for specific detection of phosphorylated and non-phosphorylated Hepatitis B core antigensRene Geissler, Megha Patel, Mark Anderson, et al.
Plos One|December 4, 2014
Antiviral interferon-beta signaling induced by designed transcription activator-like effectors (TALE)Ivonne Renner, Nancy Funk, Rene Geissler, et al.
Genes & Development|May 7, 2016
A widespread sequence-specific mRNA decay pathway mediated by hnRNPs A1 and A2/B1Rene Geissler, Alfred Simkin, Doreen Floss, et al.
Virology|October 17, 2015
Patient-adapted, specific activation of HIV-1 by customized TAL effectors (TALEs), a proof of principle studyRene Geissler, Ilona Hauber, Nancy Funk, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 31, 2026
Enhanced HBcAg immunoassay enables detection of clinically relevant low-level HBV viremia for treatment eligibilityRene Geissler, Megha Patel, Anika Koehler, et al.
Clinical Chemistry and Laboratory Medicine|February 17, 2023
Pre-analytical considerations in the development of a prototype SARS-CoV-2 antigen ARCHITECT automated immunoassayPhilip M Hemken, Eitan Israeli, Russell Taylor, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|December 14, 2017
Characterizing mRNA Sequence Motifs in the 3'-UTR Using GFP Reporter ConstructsRene Geissler, Andrew Grimson
RNA Biology|August 27, 2016
A position-specific 3'UTR sequence that accelerates mRNA decayRene Geissler, Andrew Grimson
Nucleic Acids Research|February 11, 2012
The DEAD-box helicase DDX3 supports the assembly of functional 80S ribosomesRene Geissler, Ralph P Golbik, Sven-Erik Behrens
Plos Genetics|February 4, 2020
Evolutionary dynamics of microRNA target sites across vertebrate evolutionAlfred Simkin, Rene Geissler, Alexa B R McIntyre, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 5, 2023
Novel fully automated prototype assays for specific detection of phosphorylated and non-phosphorylated Hepatitis B core antigensRene Geissler, Megha Patel, Mark Anderson, et al.
Plos One|December 4, 2014
Antiviral interferon-beta signaling induced by designed transcription activator-like effectors (TALE)Ivonne Renner, Nancy Funk, Rene Geissler, et al.
Genes & Development|May 7, 2016
A widespread sequence-specific mRNA decay pathway mediated by hnRNPs A1 and A2/B1Rene Geissler, Alfred Simkin, Doreen Floss, et al.
Virology|October 17, 2015
Patient-adapted, specific activation of HIV-1 by customized TAL effectors (TALEs), a proof of principle studyRene Geissler, Ilona Hauber, Nancy Funk, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 31, 2026
Enhanced HBcAg immunoassay enables detection of clinically relevant low-level HBV viremia for treatment eligibilityRene Geissler, Megha Patel, Anika Koehler, et al.
Clinical Chemistry and Laboratory Medicine|February 17, 2023
Pre-analytical considerations in the development of a prototype SARS-CoV-2 antigen ARCHITECT automated immunoassayPhilip M Hemken, Eitan Israeli, Russell Taylor, et al.
Pageof 1